Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wen‐Pin Su
Observed names:
Su, Wen-Pin,
W-P. Su,
W. Su,
Wen-Pin Su
Institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
Observed institutions:
National Taiwan University,
National Taiwan University Hospital,
National Cheng Kung University Hospital,
National Yang Ming University,
National Cheng Kung University
ORCID:
0000-0003-0863-203X
Observed ORCID:
0000-0003-0863-203X
OpenAlex ID:
A5062527318
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
2005
·
Jin‐Yuan Shih
, Chien‐Hung Gow
, et al.
·
International Journal of Cancer
·
174
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
2012
·
Wu-Chou Su
, Wen-Pin Su
, et al.
·
International Journal of Nanomedicine
·
162
PDF
Metformin Enhances Cisplatin Cytotoxicity by Suppressing Signal Transducer and Activator of Transcription–3 Activity Independently of the Liver Kinase B1–AMP-Activated Protein Kinase Pathway
2013
·
Chien-Chung Lin
, Hsuan-Heng Yeh
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
107
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
2019
·
Daniel P Petrylak
, Ronald de Wit
, et al.
·
The Lancet Oncology
·
94
Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
2020
·
Tilahun Ayane Debele
, Cheng-Fa Yeh
, et al.
·
Cancers
·
90
PDF
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer
2010
·
Wen-Pin Su
, Yen-Ting Chen
, et al.
·
Lung Cancer
·
87
Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments
2023
·
Liu-Chun Wang
, Pei-Yu Chiou
, et al.
·
Nature Communications
·
67
PDF
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
2006
·
Chih‐Hsin Yang
, Jin‐Yuan Shih
, et al.
·
Cancer
·
57
1550 nm excitation-responsive upconversion nanoparticles to establish dual-photodynamic therapy against pancreatic tumors
2020
·
Khang-Yen Pham
, Liu-Chun Wang
, et al.
·
Journal of Materials Chemistry B
·
53
Atomically dispersed golds on degradable zero-valent copper nanocubes augment oxygen driven Fenton-like reaction for effective orthotopic tumor therapy
2022
·
Liu-Chun Wang
, Li-Chan Chang
, et al.
·
Nature Communications
·
43
PDF
Polyaniline-Based Glyco-Condensation on Au Nanoparticles Enhances Immunotherapy in Lung Cancer
2022
·
Wen-Pin Su
, Li-Chan Chang
, et al.
·
ACS Applied Materials & Interfaces
·
43
Polysaccharide and protein-based functional wound dressing materials and applications
2020
·
Tilahun Ayane Debele
, Wen-Pin Su
·
International Journal of Polymeric Materials
·
41
Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer
2024
·
Fei-Ting Hsu
, Ying-Tzu Chen
, et al.
·
ACS Nano
·
38
PDF
Synchronization of Nanoparticle Sensitization and Radiosensitizing Chemotherapy through Cell Cycle Arrest Achieving Ultralow X-ray Dose Delivery to Pancreatic Tumors
2021
·
Divinah Manoharan
, Li-Chan Chang
, et al.
·
ACS Nano
·
38
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
2010
·
C-C. Lin
, L-C. Chen
, et al.
·
European Respiratory Journal
·
37
PDF
Redox disruption using electroactive liposome coated gold nanoparticles for cancer therapy
2025
·
Ying-Chi Chen
, Li-Chan Chang
, et al.
·
Nature Communications
·
33
PDF
Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial–Mesenchymal Transition
2015
·
Che-Yu Hsu
, Cheng-Han Lin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
31
Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pancreatic Cancer
2020
·
Tilahun Ayane Debele
, Hung-Chang Wu
, et al.
·
Pharmaceutics
·
23
PDF
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
2017
·
Wen-Pin Su
, Yen-Chih Ho
, et al.
·
Scientific Reports
·
21
PDF
Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma
2014
·
Wen-Pin Su
, Sen-Huei Hsu
, et al.
·
Oncotarget
·
20
Activation of the Signal Transducer and Activator of Transcription 3 Pathway Up-Regulates Estrogen Receptor-β Expression in Lung Adenocarcinoma Cells
2011
·
Hao-Chen Wang
, Hsuan-Heng Yeh
, et al.
·
Molecular Endocrinology
·
18
PDF
Enfortumab vedotin (EV) in combination with pembrolizumab (P) versus chemotherapy in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC): Subgroup analyses results from EV-302, a phase 3 global study.
2024
·
Michiel Simon Van Der Heijden
, Thomas Powles
, et al.
·
Journal of Clinical Oncology
·
17
The HLTF–PARP1 interaction in the progression and stability of damaged replication forks caused by methyl methanesulfonate
2020
·
Jia-Lin Shiu
, Cheng-Kuei Wu
, et al.
·
Oncogenesis
·
16
PDF
Verification of Wild-Type EGFR Status in Non–Small Cell Lung Carcinomas Using a Mutant-Enriched PCR on Selected Cases
2014
·
Yi-Lin Chen
, Cheng-Chan Lu
, et al.
·
Journal of Molecular Diagnostics
·
16
Chemical Structure and Shape Enhance MR Imaging-Guided X-ray Therapy Following Marginative Delivery
2022
·
Liu-Chun Wang
, Li-Chan Chang
, et al.
·
ACS Applied Materials & Interfaces
·
13
Show more works
View as search
Works count:
48
Citation count:
1,442
H-index:
20
I10-index:
31
Year
Topic
Type